Geschäftsbericht der Lindenhofgruppe 2021

Thema Fachgebiet Ansprechperson Lindenhofgruppe Kooperationspartner / Sponsor Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients with Neovascular Age-related Macular Degeneration Combined Protocol & Feasibility: Study 20968 Ph III – Afliber- cept High Dose VAY 865321 – in patients with Age-related Macular Degeneration (20968 PULSAR Study/PXL 245919) Ophthalmologie Prof. Dr. med. Justus G. Garweg BAYER AG Validation of Biomarker Assays for Ophthalmo- logical Diseases (2021-02499) Ophthalmologie Prof. Dr. med. Justus G. Garweg BAYER AG Impact of ILM peeling for primary rhegmatogenous retinal detachment – the I-Peel Study Ophthalmologie Prof. Dr. med. Justus G. Garweg Campus Stiftung Lindenhof Bern (SLB) Study comPARing eaRly extension Of Aflibercept and Brolucizumab in Wet AMD (SPARROW) Ophthalmologie Prof. Dr. med. Justus G. Garweg Campus Stiftung Lindenhof Bern (SLB); medignition AG und Oculocare medical AG The role of CD163 as a marker of disease activity in neovascular AMD (2020-02483) Ophthalmologie Prof. Dr. med. Justus G. Garweg Hamid Ahmadieh (Deputy Director of Research, Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran); Ali Hafezi-Moghadam (Harvard Medical School) Aqueous Humor, Blood and Imaging Biomarker Study with DME, AMD AND Cataract Patients (2021-01625) Ophthalmologie Prof. Dr. med. Justus G. Garweg Hoffmann-La Roche Mediators influencing vascular and retinal neurodegeneration in diabetes – a pilot study (2021-00248) Ophthalmologie Prof. Dr. med. Justus G. Garweg Hoffmann-La Roche Biophysical and Functional Analysis and Characterization of Retinal Retention Approaches (2021-02498) Ophthalmologie Prof. Dr. med. Justus G. Garweg Hoffmann-La Roche Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration (FALCON CRTH258ADE01) Ophthalmologie Prof. Dr. med. Justus G. Garweg Novartis Pharmaceuticals Cytokines as Biomarkers of early neuroretinal degeneration in diabetic retinopathy (Diabetes and mediators influencing early vascular and neurodegeneration in the retina 2018-00286) Ophthalmologie Prof. Dr. med. Justus G. Garweg New approach to minimally invasive glaucoma surgery (Effekt einer Zyklodialyse zusätzlich zur Trabekulektomie ab interno (Trabektom-Operation) in der Behandlung chronischer Offenwinkel- glaukome (2021-01341)) Ophthalmologie Prof. Dr. med. Justus G. Garweg 84 Geschäftsbericht 2021 Lindenhofgruppe Lehre und Forschung